The present invention relates to the use of the compound ciclopirox or a pharmaceutically acceptable salt or solvate thereof for the treatment and/or prevention of congenital erythropoietic porphyria (CEP).
本发明涉及化合物
环吡酮胺或其药学上可接受的盐或溶液用于治疗和/或预防先天性红细胞生成性
卟啉症(CEP)。